parsatuzumab: Clinical Trials

4 trials of parsatuzumab, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

4 completed. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Completed 2
Phase 2	2	Completed 2

Follow parsatuzumab: new trials by email Literature Review of parsatuzumab trials Research Report on parsatuzumab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer 5-Fluorouracil, Bevacizumab, Folinic acid - Metastatic Colorectal Cancer	Phase 2	Completed	Genentech, Inc.	127	2011-11-01	2016-08-26
Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE) MEGF0444A, bevacizumab, carboplatin - Non-Squamous Non-Small Cell Lung Cancer	Phase 2	Completed	Genentech, Inc.	104	2011-06-01	2016-11-02
A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors MEGF0444A, bevacizumab, paclitaxel - Solid Cancers	Phase 1	Completed	Genentech, Inc.	64	2010-02-01	2016-11-02
A Study of the Safety and Pharmacokinetics of MEGF0444A Administered to Patients With Advanced Solid Tumors MEGF0444A - Solid Cancers	Phase 1	Completed	Genentech, Inc.	30	2009-05-22	2022-12-12

Conditions studied

Sponsors

Countries

Top investigators

Results publications